The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease

In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects...

Full description

Bibliographic Details
Main Authors: Chiyuki Awahara, Daiki Oku, Saki Furuta, Kazuya Kobayashi, Kenta Teruya, Kenichi Akaji, Yasunao Hattori
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/5/1646
_version_ 1797474376721891328
author Chiyuki Awahara
Daiki Oku
Saki Furuta
Kazuya Kobayashi
Kenta Teruya
Kenichi Akaji
Yasunao Hattori
author_facet Chiyuki Awahara
Daiki Oku
Saki Furuta
Kazuya Kobayashi
Kenta Teruya
Kenichi Akaji
Yasunao Hattori
author_sort Chiyuki Awahara
collection DOAJ
description In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors.
first_indexed 2024-03-09T20:29:11Z
format Article
id doaj.art-729c42ba1efe4d00ae669f19ffbe04f5
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T20:29:11Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-729c42ba1efe4d00ae669f19ffbe04f52023-11-23T23:27:39ZengMDPI AGMolecules1420-30492022-03-01275164610.3390/molecules27051646The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 ProteaseChiyuki Awahara0Daiki Oku1Saki Furuta2Kazuya Kobayashi3Kenta Teruya4Kenichi Akaji5Yasunao Hattori6Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Neurochemistry, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanCenter for Instrumental Analysis, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanIn this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors.https://www.mdpi.com/1420-3049/27/5/1646HTLV-1 proteaseinhibitorretro–inverso conversionhydroxyethylamine isostere
spellingShingle Chiyuki Awahara
Daiki Oku
Saki Furuta
Kazuya Kobayashi
Kenta Teruya
Kenichi Akaji
Yasunao Hattori
The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
Molecules
HTLV-1 protease
inhibitor
retro–inverso conversion
hydroxyethylamine isostere
title The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_full The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_fullStr The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_full_unstemmed The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_short The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
title_sort effects of side chain configurations of a retro inverso type inhibitor on the human t cell leukemia virus htlv 1 protease
topic HTLV-1 protease
inhibitor
retro–inverso conversion
hydroxyethylamine isostere
url https://www.mdpi.com/1420-3049/27/5/1646
work_keys_str_mv AT chiyukiawahara theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT daikioku theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT sakifuruta theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kazuyakobayashi theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kentateruya theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kenichiakaji theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT yasunaohattori theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT chiyukiawahara effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT daikioku effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT sakifuruta effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kazuyakobayashi effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kentateruya effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT kenichiakaji effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease
AT yasunaohattori effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease